[1]苏长阳,帅东东,王 磊,等.心理疗法联合氟哌噻吨美利曲辛对冠心病合并心理障碍患者临床疗效及负性情绪的影响[J].医学信息,2021,34(01):155-157.[doi:10.3969/j.issn.1006-1959.2021.01.042]
　SU Chang-yang,SHUAI Dong-dong,WANG Lei,et al.Psychotherapy Combined with Flupentixol-melitracen on the Clinical Efficacy and Negative Emotion of Patients with Coronary Heart Disease Complicated by Psychological Disorders[J].Medical Information,2021,34(01):155-157.[doi:10.3969/j.issn.1006-1959.2021.01.042]
点击复制

心理疗法联合氟哌噻吨美利曲辛对冠心病合并心理障碍患者临床疗效及负性情绪的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年01期
页码:
155-157
栏目:
药物与临床
出版日期:
2021-01-01

文章信息/Info

Title:
Psychotherapy Combined with Flupentixol-melitracen on the Clinical Efficacy and Negative Emotion of Patients with Coronary Heart Disease Complicated by Psychological Disorders
文章编号:
1006-1959（2021）01-0155-03
作者:
苏长阳; 帅东东; 王 磊; 等
（首都医科大学石景山教学医院/北京市石景山医院心内科，北京 100043）
Author(s):
SU Chang-yang; SHUAI Dong-dong; WANG Lei; et al.
(Department of Internal Medicine-Cardiovascular, Shijingshan Teaching Hospital of Capital Medical University/ Beijing Shijingshan Hospital,Beijing 100043,China)
关键词:
心理疗法; 氟哌噻吨美利曲辛片; 冠心病; 心理障碍; 负性情绪
Keywords:
Psychotherapy; Flupentixol-melitracen; Coronary heart disease; Psychological disorders; Negative emotions
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2021.01.042
文献标志码:
A
摘要:
目的 观察心理疗法联合氟哌噻吨美利曲辛治疗冠心病合并心理障碍患者临床疗效以及对负性情绪的影响。方法 选取2019年1月~2020年1月我院收治的80例冠心病合并心理障碍患者作为研究对象，采用随机数字表法分为对照组和观察组，各40例。对照组给予常规治疗，观察组在对照组组基础上给予氟哌噻吨美利曲辛和心理疗法，比较两组临床治疗总有效率、GAD-7评分、PHQ-9评分、治疗依从性以及临床不良反应发生情况。结果 观察组治疗总有效率为97.50%，高于对照组的85.00%，差异有统计学意义（P＜0.05）；治疗后，观察组GAD-7评分、PHQ-9评分低于对照组，差异有统计学意义（P＜0.05）；观察组治疗依从性为92.50%，高于对照组的82.50%，差异有统计学意义（P＜0.05）；观察组临床不良反应发生率为5.00%，与对照组的2.50%比较，差异无统计学意义（P＞0.05）。结论 心理疗法联合氟哌噻吨美利曲辛治疗冠心病合并心理障碍患者效果确切，可改善患者焦虑、抑郁情绪，提高治疗依从性，且不增加不良反应发生几率。
Abstract:
Objective To observe the clinical efficacy of psychotherapy combined with flupentixol-melitracen in the treatment of patients with coronary heart disease complicated by psychological disorders and its influence on negative emotions.Methods A total of 80 patients with coronary heart disease and mental disorders admitted to our hospital from January 2019 to January 2020 were selected as the research objects, and were divided into the control group and the observation group by random number table method, with 40 cases in each group. The control group was given conventional treatment, and the observation group was given flupentixol-melitracen and psychotherapy on the basis of the control group. The total effective rate of clinical treatment, GAD-7 score and PHQ-9 score, compliance rate and clinical adverse reactions.Results The total effective rate of treatment in the observation group was 97.50%, which was higher than 85.00% in the control group,the difference was statistically significant (P＜0.05); after treatment, the GAD-7 score and PHQ-9 score of the observation group were lower than those of the control group,the difference was statistically significant (P＜0.05); The compliance rate of the observation group was 92.50%, which was higher than 82.50% of the control group,the difference was statistically significant (P＜0.05); the incidence of clinical adverse reactions in the observation group was 5.00%,compared with 2.50% of the control group, the difference was not statistically significant (P>0.05).Conclusion Psychotherapy combined with flupentixol-melitracen is effective in the treatment of patients with coronary heart disease complicated by psychological disorders. It can improve patients’ anxiety and depression, improve compliance with doctors, and does not increase the probability of adverse reactions.

参考文献/References:

[1]王启辉,陈丽霞,王思洋,等.草酸艾司西酞普兰对冠心病伴焦虑抑郁患者负性情绪及心功能的影响[J].实用心脑肺血管病杂志,2019,27(11):85-88. [2]张佳丽,张涵玉,陈利静,等.氟哌噻吨美利曲辛片在100例冠心病伴情绪障碍患者治疗中的应用[J].上海医药,2020,41(7):26-27,78. [3]王勇霞.氟哌噻吨美利曲辛片对老年冠心病合并焦虑患者的影响分析[J].中国社区医师,2018,34(24):53,55. [4]霍金华,徐诺.心理干预对心血管病与心理障碍共病的影响[J].中西医结合心血管病电子杂志,2016,4(3):109-110． [5]丁妍,余健,黄贤珍,等.双心护理在冠心病患者中的应用效果[J].广东医学,2017,38(16):2576-2579. [6]王融,石纪萍,杜丽萍,等.曲美他嗪联合黛力新对冠脉旁路移植术后心绞痛伴抑郁患者疗效[J].包头医学院学报,2015,31(12):19-21. [7]陈业雄,符峰梁.氟哌噻吨美利曲辛片治疗老年冠心病伴焦虑患者的疗效[J].中国老年学杂志,2015,33(24):6107-6108. [8]尉希凤,赵启君.抗焦虑抑郁治疗应用于双心疾病的临床疗效分析[J].中国卫生标准管理,2016,7(22):35 [9]Schalet BD,Cook KF,Choi SW,et al.Establishing a common metric for self-reported anxiety: linking the MASQ, PANAS, and GAD-7 to PROMIS Anxiety[J].J Anxiety Disord,2014,28(1):88-96. [10]Wang W,Bian Q,Zhao Y,et al.Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population[J].Gen Hosp Psychiatry,2014,36(5):539-544. [11]梁艺,张景昌,黄学成,等.心理干预对冠心病慢性心力衰竭合并焦虑、抑郁患者的疗效分析[J].中国临床医生杂志,2017,45(2):47-49. [12]张丽君,黄淑田,孙丽丽,等.冠心病伴焦虑、抑郁症状患者实施心理干预的效果评价[J].中国心血管病研究,2014,12(11):965-968. [13]辛若丹,李文森,管考华,等.焦虑抑郁障碍与冠心病的相关性[J].中国老年学杂志,2017,37(6):1556-1559. [14]李双勇,张蕾,黄亮明,等.氟哌噻吨美利曲辛片治疗伴有焦虑和(或)抑郁的咽异感症患者的疗效[J].实用医学杂志,2016,32(24):4100-4104.

相似文献/References:

[1]曹火留,张 璋,黄学勤.黛力新联合维生素B6治疗伴负性情绪的功能性消化不良临床疗效研究[J].医学信息,2018,31(22):60.[doi:10.3969/j.issn.1006-1959.2018.22.017]
　CAO Huo-liu,ZHANG Zhang,HUANG Xue-qin.Efficacy of Deanxit and VitB6 tablets in management of negative emotions in patients with Functional dyspepsia[J].Medical Information,2018,31(01):60.[doi:10.3969/j.issn.1006-1959.2018.22.017]
[2]谢 燕,马 珍,张珺珺.氟哌噻吨美利曲辛片联合舒肝解郁胶囊治疗难治性胃食管反流病的疗效[J].医学信息,2021,34(05):161.[doi:10.3969/j.issn.1006-1959.2021.05.046]
　XIE Yan,MA Zhen,ZHANG Jun-jun.Efficacy of Flupentixol and Melitroxin Tablets Combined with Shugan Jieyu Capsule in the Treatment of Refractory Gastroesophageal Reflux Disease[J].Medical Information,2021,34(01):161.[doi:10.3969/j.issn.1006-1959.2021.05.046]
[3]王 婧.枳术宽中胶囊治疗伴有焦虑及抑郁状态的非糜烂性胃食管反流病的疗效观察[J].医学信息,2021,34(15):181.[doi:10.3969/j.issn.1006-1959.2021.15.051]
　WANG Jing.Observation on the Efficacy of Zhizhu Kuanzhong Jiaonang in Treating Non-erosive Gastroesophageal Reflux Disease with Anxiety and Depression[J].Medical Information,2021,34(01):181.[doi:10.3969/j.issn.1006-1959.2021.15.051]

更新日期/Last Update: 1900-01-01